The growing class of drugs known as GLP-1 receptor agonists are changing blood sugar treatment, but the route of administration is becoming a key factor . Traditionally , these beneficial medications were offered solely in pill form. However, new transdermal systems are now being introduced, prompting many people to ask which choice is preferable.